Envestnet Asset Management
ALT icon

Envestnet Asset Management’s Altimmune ALT Stock Holding History

Envestnet Asset Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,908
Closed -$127K – 4511
2025
Q2 		$127K Buy
32,908
+10,671
+48% +$57.7K ﹤0.01% 4309
2025
Q1 		$111K Buy
+22,237
New +$141K ﹤0.01% 4222
2024
Q4 		– Sell
-19,084
Closed -$117K – 4301
2024
Q3 		$117K Sell
19,084
-8,732
-31% -$59.2K ﹤0.01% 4111
2024
Q2 		$185K Sell
27,816
-8,717
-24% -$64.3K ﹤0.01% 3953
2024
Q1 		$372K Buy
+36,533
New +$372K ﹤0.01% 3611
2023
Q3 		– Sell
-30,986
Closed -$109K – 4009
2023
Q2 		$109K Buy
30,986
+7,984
+35% +$35.8K ﹤0.01% 3823
2023
Q1 		$97.1K Buy
+23,002
New +$273K ﹤0.01% 3799
2021
Q4 		– Sell
-15,168
Closed -$172K – 3868
2021
Q3 		$172K Buy
+15,168
New +$184K ﹤0.01% 3528

Other funds holding ALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Envestnet Asset Management's ALT Position: Q3 2025 in Review

Envestnet Asset Management sold out of Altimmune (ALT) in Q3 2025, closing a stake of 32,908 shares — an estimated $127K sold.

Envestnet Asset Management first reported a position in ALT in Q3 2021 and held it in 8 quarters. The position peaked at $372K in Q1 2024. 158 funds tracked by Wall St. Rank hold ALT as of Q3 2025.

  • Envestnet Asset Management reported no remaining Altimmune position as of Q3 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 32,908 Altimmune shares in Q3 2025, an estimated $127K.
  • Envestnet Asset Management first reported a position in Altimmune in Q3 2021 and held it in 8 quarters.
  • Envestnet Asset Management's Altimmune position peaked at $372K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Altimmune as of Q3 2025.

Based on Envestnet Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.